PC(18:2(9Z,12Z)/18:0)
|
Basic information |
| Metabolite name | PC(18:2(9Z,12Z)/18:0) |
 | HMDB0008135 |
 |
C00157 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 1 |
|
Basic information |
| Metabolite name | PC(18:2(9Z,12Z)/18:0) |
| HMDB0008135 |
|
C00157 |
|
N/A |
| Synonyms | NA |
| No. of studies | 1 |
|
Relationship between PC(18:2(9Z,12Z)/18:0) and depression (count: 1) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M949 | Type1 | ovariectomy group vs. control group | Serum | ICR mouse | Down |
| Study M949 | Type2 | ovariectomy + high dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + middle dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + fluoxetine group vs. ovariectomy group | Serum | ICR mouse | Up |
| Study M949 | Type2 | ovariectomy + low dose of Ginseng total saponins and Fuzi total alkaloids group vs. ovariectomy group | Serum | ICR mouse | Up |